Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

29.57
Delayed Data
As of Jul 22
 -0.19 / -0.64%
Today’s Change
25.98
Today|||52-Week Range
40.69
-8.28%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line38.8M35.1M16.9M-55.6M
 
 
 
 
 
Depreciation65.5M81.7M86.1M89.9M
 
 
 
 
 
Total Other Cash Flow17.4M21.0M19.7M114.8M
 
 
 
 
 
Funds From Operations122.3M137.6M126.8M148.1M
 
 
 
 
 
Funds From/For Other Operating Expenses37.2M-1.9M-331.0K26.2M
 
 
 
 
 
Net Cash Flow - Operating Activities85.1M139.5M127.2M121.9M
 
 
 
 
 
 
InvestingIncrease In Investments-1.0M-23.1M0.000.00
 
 
 
Capital Expenditures-62.2M-73.6M-122.2M-102.4M
 
 
 
 
 
Fixed Asset Disposal2.0M488.0K452.0K637.0K
 
 
 
 
 
Net Assets From Acquisitions -535.2M-9.5M0.000.00
 
 
 
Other Investing - Uses0.000.000.00-3.0M
 
 
Net Cash Flow Investing-596.4M-105.8M-121.8M-104.8M
 
 
 
 
 
 
FinancingShort Term Borrowings7.4M-5.5M843.0K2.3M
 
 
 
 
 
Long Term Borrowings469.5M0.00-1.0M--
 
 
 
Long Term Debt Reduction-886.0K-38.0M-9.6M-22.3M
 
 
 
 
 
Net Proceeds Stock Sale31.7M20.5M14.1M18.4M
 
 
 
 
 
Common Preferred Redeemed-50.0M0.00-39.0M-61.0M
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing4.1M2.4M1.6M0.00
 
 
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing461.9M-20.7M-33.2M-62.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-273.0K355.0K-4.1M-12.0K
 
 
 
 
 
 
Net Change In Cash-49.5M13.0M-27.8M-45.5M